Home › Free Stock Grades › EYPT
EyePoint Pharmaceuticals, Inc. (EYPT) Stock Grade
EYPT · Healthcare
C
Market Cap
$277.5M
P/E Ratio
—
Revenue Growth (YoY)
-27.5%
Net Margin
-739.4%
Return on Equity
—
Dividend Yield
None
About EyePoint Pharmaceuticals, Inc.'s fundamentals
EyePoint Pharmaceuticals is a biotechnology company with a market capitalization of $277.5 million that reported a net loss in its latest annual statement, resulting in a net margin of -739.4%. The company experienced significant revenue decline, with year-over-year revenue falling 27.5%, indicating contracting sales. The company does not currently pay a dividend to shareholders. Standard profitability metrics like P/E ratio and return on equity are not applicable given the company's loss-making status.